相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。KDS2010: A Potent Highly Selective and Reversible MAO-B Inhibitor for Alzheimer's Disease
Abdullah Al Mamun et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2020)
Emerging Potential of Naturally Occurring Autophagy Modulators Against Neurodegeneration
Md. Ataur Rahman et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
Md. Sahab Uddin et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer's Disease
Md Sahab Uddin et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Emerging Promise of Immunotherapy for Alzheimer's Disease: A New Hope for the Development of Alzheimer's Vaccine
Md. Tanvir Kabir et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Combination Drug Therapy for the Management of Alzheimer's Disease
Md. Tanvir Kabir et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
TV 3326 for Alzheimer's dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer's-like neuropathology
Md. Sahab Uddin et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer's Disease
Md Sahab Uddin et al.
MOLECULAR NEUROBIOLOGY (2020)
Estrogen Signaling in Alzheimer's Disease: Molecular Insights and Therapeutic Targets for Alzheimer's Dementia
Md. Sahab Uddin et al.
MOLECULAR NEUROBIOLOGY (2020)
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease
Md. Sahab Uddin et al.
MOLECULES (2020)
Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease
Abdullah Al Mamun et al.
NEUROTOXICITY RESEARCH (2020)
Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
Md Sahab Uddin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease
Abdullah Al Mamun et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Circadian and sleep dysfunction in Alzheimer's disease
Md Sahab Uddin et al.
AGEING RESEARCH REVIEWS (2020)
Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease
Md Sahab Uddin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration
Md Sahab Uddin et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Toxic tau: structural origins of tau aggregation in Alzheimer's disease
Abdullah Al Mamun et al.
NEURAL REGENERATION RESEARCH (2020)
Analyzing the chance of developing dementia among geriatric people: a cross-sectional pilot study in Bangladesh
Md Sahab Uddin et al.
PSYCHOGERIATRICS (2019)
Advancements in nanotherapeutics for Alzheimer's disease: current perspectives
Seetha Harilal et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology
Md Farhad Hossain et al.
MOLECULAR NEUROBIOLOGY (2019)
Emerging Signal Regulating Potential of Genistein Against Alzheimer's Disease: A Promising Molecule of Interest
Md Sahab Uddin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
Md Tanvir Kabir et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Md Tanvir Kabir et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
Ronen Ben Jehuda et al.
STEM CELL REVIEWS AND REPORTS (2018)
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
Ronen Ben Jehuda et al.
STEM CELL REVIEWS AND REPORTS (2018)
Spectrum of Disease and Prescription Pattern for Outpatients with Neurological Disorders: An Empirical Pilot Study in Bangladesh
Md. Sahab Uddin et al.
ANNALS OF NEUROSCIENCES (2018)
Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase
Linfeng Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The genes associated with early-onset Alzheimer’s disease
Meng-Hui Dai et al.
Oncotarget (2017)
APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease
J. I. Velez et al.
MOLECULAR PSYCHIATRY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Loss of Aβ43 Production Caused by Presenilin-1 Mutations in the Knockin Mouse Brain
Dan Xia et al.
NEURON (2016)
First Report of PSEN2 Mutation Presenting as Posterior Cortical Atrophy
Lucio Tremolizzo et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2015)
An atomic structure of human γ-secretase
Xiao-chen Bai et al.
NATURE (2015)
Presenilin-1 Knockin Mice Reveal Loss-of-Function Mechanism for Familial Alzheimer's Disease
Dan Xia et al.
NEURON (2015)
Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders
Yan Cai et al.
CLINICAL INTERVENTIONS IN AGING (2015)
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Christiane Reitz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Pen-2 Is Essential for γ-Secretase Complex Stability and Trafficking but Partially Dispensable for Endoproteolysis
Oliver Holmes et al.
BIOCHEMISTRY (2014)
Probable novel PSEN2 Val214Leu mutation in Alzheimer's disease supported by structural prediction
Young Chul Youn et al.
BMC NEUROLOGY (2014)
Previously Unrecognized Missense Mutation E126K of PSEN2 Segregates with Early Onset Alzheimer's Disease in a Family
Ulrich Mueller et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
γ-Secretase Processing and Effects of γ-Secretase Inhibitors and Modulators on Long Aβ Peptides in Cells
Yong Ran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A novel mutation in the PSEN2 gene (N141Y) associated with early-onset autosomal dominant Alzheimer's disease in a Chinese Han family
Fusheng Niu et al.
NEUROBIOLOGY OF AGING (2014)
Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease
Celeste Sassi et al.
NEUROBIOLOGY OF AGING (2014)
Symptom onset in autosomal dominant Alzheimer disease A systematic review and meta-analysis
Davis C. Ryman et al.
NEUROLOGY (2014)
NOVEL PRESENILIN MUTATIONS WITHIN MOROCCAN PATIENTS WITH EARLY-ONSET ALZHEIMER'S DISEASE
N. El Kadmiri et al.
NEUROSCIENCE (2014)
Structural Interactions between Inhibitor and Substrate Docking Sites Give Insight into Mechanisms of Human PS1 Complexes
Yi Li et al.
STRUCTURE (2014)
Disease-related mutations among Caribbean Hispanics with familial dementia
Joseph H. Lee et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2014)
Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Teng Jiang et al.
Current Alzheimer Research (2013)
Trans-Dominant Negative Effects of Pathogenic PSEN1 Mutations on γ-Secretase Activity and Aβ Production
Elizabeth A. Heilig et al.
JOURNAL OF NEUROSCIENCE (2013)
Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease
Thomas S. Wingo et al.
ARCHIVES OF NEUROLOGY (2012)
Locus-specific mutation databases for neurodegenerative brain diseases
Marc Cruts et al.
HUMAN MUTATION (2012)
Autosomal Dominant Alzheimer's Disease with Early Frontal Lobe Involvement Associated with the Met239Ile Mutation of Presenilin 2 Gene
Silvia Testi et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The French Series of Autosomal Dominant Early Onset Alzheimer's Disease Cases: Mutation Spectrum and Cerebrospinal Fluid Biomarkers
David Wallon et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Conditional Deletion of Notch1 and Notch2 Genes in Excitatory Neurons of Postnatal Forebrain Does Not Cause Neurodegeneration or Reduction of Notch mRNAs and Proteins
Jin Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Pen-2 is dispensable for endoproteolysis of presenilin 1, and nicastrin-Aph subcomplex is important for both γ-secretase assembly and substrate recruitment
Guozhang Mao et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Familial Frontotemporal Dementia-Associated Presenilin-1 c.548G> T Mutation Causes Decreased mRNA Expression and Reduced Presenilin Function in Knock-In Mice
Hirotaka Watanabe et al.
JOURNAL OF NEUROSCIENCE (2012)
Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort
Valerija Dobricic et al.
NEUROBIOLOGY OF AGING (2012)
Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients
Ebba Lohmann et al.
NEUROBIOLOGY OF AGING (2012)
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?
Bram Meeus et al.
NEUROBIOLOGY OF AGING (2012)
Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
Carlos Cruchaga et al.
PLOS ONE (2012)
Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease
Sascha Weggen et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Alzheimer's Association Report 2011 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2011)
The Human Brain in a Dish: The Promise of iPSC-Derived Neurons
Ricardo Dolmetsch et al.
CELL (2011)
Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations
Frank Soldner et al.
CELL (2011)
Presenilin-1 mutation Alzheimer's disease: A genetic epilepsy syndrome?
A. J. Larner
EPILEPSY & BEHAVIOR (2011)
Recombinase-Mediated Cassette Exchange (RMCE): Traditional Concepts and Current Challenges
Soeren Turan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Novel Research Horizons for Presenilins and gamma-Secretases in Cell Biology and Disease
Bart De Strooper et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26 (2010)
Correlating familial Alzheimer's disease gene mutations with clinical phenotype
Natalie S. Ryan et al.
BIOMARKERS IN MEDICINE (2010)
Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2
Suman Jayadev et al.
BRAIN (2010)
Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations
Ju-Hyun Lee et al.
CELL (2010)
Familial Alzheimer's disease co-segregates with a Met 146 Ile substitution in presenilin-1
Poul Jørgensen et al.
CLINICAL GENETICS (2010)
Alzheimer Disease
Rudy J. Castellani et al.
DM DISEASE-A-MONTH (2010)
A Novel Mutation in the Predicted TMIII Domain of the PSEN2 Gene in an Italian Pedigree with Atypical Alzheimer's Disease
Paola Piscopo et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of γ-Secretase Activity
Elizabeth A. Heilig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
Rita Joao Guerreiro et al.
NEUROBIOLOGY OF AGING (2010)
Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia
Maura Gallo et al.
NEUROLOGICAL SCIENCES (2010)
Characterization of Age-Dependent and Progressive Cortical Neuronal Degeneration in Presenilin Conditional Mutant Mice
Mary Wines-Samuelson et al.
PLOS ONE (2010)
γ-Secretase Gene Mutations in Familial Acne Inversa
Baoxi Wang et al.
SCIENCE (2010)
Genetic testing in familial AD and FTD: Mutation and phenotype spectrum in a Danish cohort
S. G. Lindquist et al.
CLINICAL GENETICS (2009)
A Novel Italian Presenilin 2 Gene Mutation with Prevalent Behavioral Phenotype
Gabriella Marcon et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
APH1 Polar Transmembrane Residues Regulate the Assembly and Activity of Presenilin Complexes
Raphaelle Pardossi-Piquard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Deviant Ryanodine Receptor-Mediated Calcium Release Resets Synaptic Homeostasis in Presymptomatic 3xTg-AD Mice
Shreaya Chakroborty et al.
JOURNAL OF NEUROSCIENCE (2009)
Presenilins are essential for regulating neurotransmitter release
Chen Zhang et al.
NATURE (2009)
A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction
Andreas Puschmann et al.
PARKINSONISM & RELATED DISORDERS (2009)
γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease
Lutgarde Serneels et al.
SCIENCE (2009)
P3-213: Genetic screening in a large cohort of early-onset Alzheimer's disease patients from Spain: Novel mutations in the amyloid precursor protein and presenilines
Jordi Clarimón et al.
Alzheimers & Dementia (2008)
Molecular genetics of Alzheimer's disease: An update
Nathalie Brouwers et al.
ANNALS OF MEDICINE (2008)
Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer's disease
Daniel R. Dries et al.
CURRENT ALZHEIMER RESEARCH (2008)
A novel presenilin 2 mutation (V393M) in early-onset dementia with profound language impairment
S. G. Lindquist et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Late onset familial Alzheimer's disease: novel presenilin 2 mutation and PS1 E318G polymorphism
Livia Bernardi et al.
JOURNAL OF NEUROLOGY (2008)
Plasma amyloid ß protein is elevated in late-onset Alzheimer disease families
N. Ertekin-Taner et al.
NEUROLOGY (2008)
A novel PSEN2 mutation associated with a peculiar phenotype
P. Piscopo et al.
NEUROLOGY (2008)
The pathogenesis of alzheimers disease - Is it a lifelong Calciumopathy?
Grace E. Stutzmann
NEUROSCIENTIST (2007)
A role for presenilin in post-stress regulation:: effects of presenilin mutations on Ca2+ currents in Drosophila
Yisheng Lu et al.
FASEB JOURNAL (2007)
When loss is gain:: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40 -: Talking Point on the role of presenilin mutations in Alzheimer disease
Michael S. Wolfe
EMBO REPORTS (2007)
Rer1p competes with APH-1 for binding to nicastrin and regulates γ-secretase complex assembly in the early secretory pathway
Dragana Spasic et al.
JOURNAL OF CELL BIOLOGY (2007)
The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism
Jie Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Presenilin 2 Ser130Leu mutation in a case of late-onset sporadic Alzheimer's disease
Carmine Tomaino et al.
JOURNAL OF NEUROLOGY (2007)
Mutations of presenilin genes in dilated cardiomyopathy and heart failure
Duanxiang Li et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations
Huiping Tu et al.
CELL (2006)
Functional characterization of novel presenilin-2 variants identified in human breast cancers
M. D. To et al.
ONCOGENE (2006)
Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels
Giancarlo Zatti et al.
CELL CALCIUM (2006)
TMP21 is a presenilin complex component that modulates γ-secretase but not ε-secretase activity
FS Chen et al.
NATURE (2006)
Role of genes and environments for explaining Alzheimer disease
M Gatz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Evidence that the NF motif in transmembrane domain 4 of presenilin 1 is critical for binding with PEN-2
SH Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pen-2 is incorporated into the γ-secretase complex through binding to transmembrane domain 4 of presenilin 1
N Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nicastrin functions as a γ-secretase-substrate receptor
S Shah et al.
CELL (2005)
Novel mutations and repeated findings of mutations in familial Alzheimer disease
U Finckh et al.
NEUROGENETICS (2005)
Nicastrin is critical for stability and trafficking but not association of other presenilin/γ-secretase components
YW Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia
M Giacomello et al.
NEUROBIOLOGY OF DISEASE (2005)
A sequence within the first transmembrane domain of PEN-2 is critical for PEN-2-mediated endoproteolysis of presenilin 1
SH Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in A beta 42/40 ratios
ES Walker et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration
CA Saura et al.
NEURON (2004)
The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores
G Zatti et al.
NEUROBIOLOGY OF DISEASE (2004)
Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene
G Marcon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
A conserved GXXXG motif in APH-1 is critical for assembly and activity of the γ-secretase complex
SF Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer's-Linked mutation in Presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability
GE Stutzmann et al.
JOURNAL OF NEUROSCIENCE (2004)
Octapeptide repeat insertions in the prion protein gene and early onset dementia
EA Croes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
The presenilin proteins are components of multiple membrane-bound complexes that have different biological activities
YJ Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Familial clustering and genetic risk for dementia in a genetically isolated Dutch population
K Sleegers et al.
BRAIN (2004)
The extreme C terminus of presenilin 1 is essential for γ-secretase complex assembly and activity
A Bergman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the γ-secretase complex
S Prokop et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Atypical dementia associated with a novel presenilin-2 mutation
G Binetti et al.
ANNALS OF NEUROLOGY (2003)
Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred
P Pastor et al.
ANNALS OF NEUROLOGY (2003)
A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease
M Ezquerra et al.
ARCHIVES OF NEUROLOGY (2003)
Membrane topology of γ-secretase component PEN-2
AS Crystal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
γ-Secretase activity is associated with a conformational change of Nicastrin
K Shirotani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Aph-1, Pen-2, and nicastrin with presenilin generate an active γ-secretase complex
B De Strooper
NEURON (2003)
APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin-nicastrin complexes
YJ Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of new presenilin gene mutations in early-onset familial Alzheimer disease
A Tedde et al.
ARCHIVES OF NEUROLOGY (2003)
Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-β precursor protein and Notch
SF Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain
A Lleó et al.
ARCHIVES OF NEUROLOGY (2002)
Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease
FM LaFerla
NATURE REVIEWS NEUROSCIENCE (2002)
Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins
DS Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
aph-1 and pen-2 are required for notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation
R Francis et al.
DEVELOPMENTAL CELL (2002)
Uncommon polymorphism in the presenilin genes in human familial Alzheimer's disease:: not to be mistaken with a pathogenic mutation
A Lleó et al.
NEUROSCIENCE LETTERS (2002)
A novel presenilin 2 gene mutation (D439A) in a patient with early-onset Alzheimer's disease
A Lleó et al.
NEUROLOGY (2001)
Nicastrin binds to membrane tethered Notch
FS Chen et al.
NATURE CELL BIOLOGY (2001)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease
G Devi et al.
ARCHIVES OF NEUROLOGY (2000)
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing
G Yu et al.
NATURE (2000)
Presenilin structure, function and role in Alzheimer disease
PE Fraser et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Calsenilin reverses presenilin-mediated enhancement of calcium signaling
MA Leissring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I
U Finckh et al.
NEUROLOGY (2000)
Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression
J Theuns et al.
HUMAN MOLECULAR GENETICS (2000)
High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes
U Finckh et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
